Cambridge Capital Group has over 80 members from a variety of backgrounds ranging from finance, technology and corporate to life sciences, agriculture and engineering. Members have invested in more than 60 live portfolio companies across Europe’s leading technology cluster since 2001. During 2016 members enjoyed four successful exits: Swiftkey, Cambridge CMOS, Oval Medical and Expedeon.
We are a syndicate member of the UK Business Angels Association (UKBAA) and our membership includes two UKBAA Investors of the Year.
We focus on businesses from Seed to Series A stage raising between £150k to £2m. We invest in B2B technology companies based on defensible intellectual property - companies meeting these requirements are invited to submit their summary using the link below.
As we continue to expand our network we invite new member applications from sophisticated investors, family offices and venture capital funds.
Cambridge Capital Group invests in early-stage opportunities – seed, start-up and early growth.
Click below to find out more about our investment criteria.
Cambridge Capital Group invests in early-stage technology companies based in The Golden Triangle.
Click below to find out more about our membership.
Cambridge Capital Limited T/A Cambridge Capital Group is not authorised under the Financial Services and Markets Act 2000. Cambridge Capital Group does not and will not give advice as to the merits of entering into any particular transaction. This communication is provided for information only and is not in any circumstances intended to constitute advice as to the merits of the recipient, or any other person buying, selling or subscribing for any investment or engaging in any other transaction. Any person seeking such advice should consult a person authorised under the Financial Services and Markets Act 2000 to give such advice. This communication is exempt from the general restriction (in section 21 of the Financial Services and Markets Act 2000) on the communication of invitations or inducements to engage in investment activity on the ground that it is made to a certified sophisticated investor or high net worth individual; and hence the content has not been approved by an authorised person.